je.st
news
Tag: therapeutics
Nasdaq Stockholm Welcomes Infant Bacterial Therapeutics to First North
2016-03-29 13:33:06| Appliances - Topix.net
Nasdaq announces that the trading in Infant Bacterial Therapeutics AB's shares commenced today on Nasdaq First North in Stockholm. IBT belongs to the health care sector and is the 12th company to be admitted to trading on Nasdaq's Nordic markets* in 2016.
Tags: north
stockholm
nasdaq
infant
Cidara Therapeutics Inc (CDTX) Rating Lowered to Hold at Zacks Investment Research
2016-03-25 03:28:33| Biotech - Topix.net
According to Zacks, "Cidara Therapeutics, Inc. is a biotechnology company. The company is focused on the discovery, development and commercialization of novel anti-infectives.
Tags: research
rating
hold
investment
Overcome Formulation Challenges Of Protein-based Therapeutics
2016-03-23 15:54:23| drugdiscoveryonline Home Page
Protein-based therapeutics have emerged as a key driver of growth in thepharmaceutical industry. R&D pipelines have filled with biologics and monoclonal antibodies havebecome the best-selling drugs around the world. Despite the success of this segment, the sizeand complexity of protein molecules create specific challenges when developing these typesof therapeutics.
Tags: challenges
overcome
formulation
therapeutics
Overcome Formulation Challenges Of Protein-based Therapeutics
2016-03-23 15:54:23| drugdiscoveryonline Home Page
Protein-based therapeutics have emerged as a key driver of growth in thepharmaceutical industry. R&D pipelines have filled with biologics and monoclonal antibodies havebecome the best-selling drugs around the world. Despite the success of this segment, the sizeand complexity of protein molecules create specific challenges when developing these typesof therapeutics.
Tags: challenges
overcome
formulation
therapeutics
Microlin Bio buys Marina Biotech's nucleic acid therapeutics assets in cash-and-stock deal
2016-03-16 19:30:38| Biotech - Topix.net
Microlin Bio and Marina Biotech execute a term sheet under which Microlin intends to acquire Marina's nucleic acid therapeutics assets for 6.7M shares of Microlin stock and ~$1M in cash. Based on the recent price of $1.50 per share of MICB, the deal is valued at slightly more than $11M.
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] next »